Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (99)

« Back to Publications

Exposure-response of ciclosporin and methotrexate in children and young people with severe atopic dermatitis: a secondary analysis of the TREatment of severe Atopic dermatitis Trial (TREAT).

Wan M. et al, (2025), Clin Exp Dermatol, 50, 1623 - 1627

The effects of ciclosporin and methotrexate on kidney function in the treatment of severe atopic dermatitis in children: results from the TREAT trial.

Bruce G. et al, (2024), Br J Dermatol, 191, 851 - 852

Neuropsychiatric diagnoses after isotretinoin initiation in pediatric acne patients: A retrospective cohort study.

Paljärvi T. et al, (2024), J Am Acad Dermatol, 91, 571 - 573

A qualitative study of psychological morbidity in paediatric survivors of Stevens-Johnson syndrome/toxic epidermal necrolysis.

Phillips C. et al, (2024), Br J Dermatol, 191, 293 - 295

Five paediatric patients with mycosis fungoides and our approach to provide age-appropriate information and psychological support.

Melchionda V. et al, (2024), Clin Exp Dermatol, 49, 497 - 501

Paediatric dermatology training experience and career intentions: a survey of UK dermatology trainees

Stokes NK. et al, (2024), BRITISH JOURNAL OF DERMATOLOGY, 191, I124 - I125

novel framework for the diagnosis, management and terminology of 'dermatitis artefacta'

Nancarrow-Lei R. et al, (2024), BRITISH JOURNAL OF DERMATOLOGY, 191, I180 - I180

A Qualitative Study of the Psychological Morbidity in Paediatric Survivors of Stevens Johnson Syndrome and Toxic Epidermal Necrolysis

Phillips C. et al, (2024), BRITISH JOURNAL OF DERMATOLOGY, 190, I2 - I2

Efficacy and safety of ciclosporin versus methotrexate in the treatment of severe atopic dermatitis in children and young people (TREAT): a multicentre parallel group assessor-blinded clinical trial.

Flohr C. et al, (2023), Br J Dermatol, 189, 674 - 684

Clinical and epidemiological features of psoriasis exacerbations in children with SARS-CoV-2 infection.

Skrek S. et al, (2023), J Eur Acad Dermatol Venereol, 37, e1192 - e1195

British Society for Paediatric and Adolescent Dermatology assessment and support of mental health in children and young people with skin conditions: a multidisciplinary expert consensus statement and recommendations.

McPherson T. et al, (2023), Br J Dermatol, 189, 459 - 466

eal-world retrospective observational study exploring NHS resource use in England for the management of moderate-to-severe atopic dermatitis in secondary care for children and adolescents.

McPherson T. et al, (2023), Pediatr Dermatol, 40, 50 - 63

Langerhans cell histiocytosis: case series of presentations to dermatology in the BRAF era

Coyle C. et al, (2023), BRITISH JOURNAL OF DERMATOLOGY, 189, E41 - E41

Blueberry muffin syndrome secondary to acute myeloid leukaemia: a learning point

Melchionda V. et al, (2023), BRITISH JOURNAL OF DERMATOLOGY, 189, E47 - E48

Clinical aspects of psoriasis flares and risk factors for developing a post-infectious flare in children with SARS-CoV-2 infection: data from the Chi-PsoCov registry

Mahe E. et al, (2023), BRITISH JOURNAL OF DERMATOLOGY, 189, E40 - E40

Load More

1
2
3
4
5
6
7